Defining CDK12 as a tumor suppressor and therapeutic target in mouse models of tubo-ovarian high-grade serous carcinoma
Jean C. Tien(University of Michigan), Arul M. Chinnaiyan(University of Michigan), Yuanyuan Qiao(University of Michigan), Jianzhang Yang(Jinan University), Jonathan Chou(UCSF Helen Diller Family Comprehensive Cancer Center), Fengyun Su(University of Michigan), Somnath Mahapatra(University of Michigan), Yu‐Sun Chang(Chang Gung University), Kathleen R. Cho(University of Michigan), Xuhong Cao(Howard Hughes Medical Institute), Rong Wu(Nanjing Forestry University), Marcin Cieślik(University of Michigan), Carmine Stolfi(University of Rome Tor Vergata), Brian Magnuson(University of Michigan), Rahul Mannan(University of Michigan), Yuping Zhang(University of Michigan), Christina Wheeler(University of Michigan), Eric R. Fearon(University of Michigan), Zhen Wang(Shanghai Institute of Organic Chemistry), Rui Wang(University of Michigan), Shuqin Li(Xuzhou Medical College), Xiaoju Wang(Shanxi Agricultural University), Yunhui Cheng(University of Michigan), Caleb Cheng(University of Michigan), Yizhi Cao(Nanjing Medical University), Lanbo Xiao(University of Michigan), Yali Zhai(University of Michigan), Abigail J. Todd(University of Michigan), Ke Ding(China Pharmaceutical University), Gabriel Cruz(Kansas City University), Licheng Zhou(Jinan University)
Cited by 6
Related Papers
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
Chromosome 17 Deletions and p53 Gene Mutations in Colorectal Carcinomas
|Science|1989|2.1k
Allelotype of Colorectal Carcinomas
|Science|1989|1.3k